Constellation Pharmaceuticals

United States
Primghar, Iowa, United States, 02139

Company profile

Constellation Pharmaceuticals company profile

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.

Business identity

Contact email
[email protected]
Phone number
6177140555
Operating status
Closed
Company type
For Profit
Employee range
101-250 employees
Founded
2008-01-01, Year

Headquarters

Postal code
02139
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
14
Total equity funding
$679.3M
Last funding
Post IPO Equity / $224.3M / 2019-12-10
Last equity funding
Post IPO Equity / $224.3M
Investors
22
Lead investors
7
Founders
3
Articles
82
Closed on
2021-07-15
Exited on
2018-07-18

Founders and investors

Founders

Danny ReinbergDavid AllisYang Shi

Lead investors

GenentechMassachusetts Clean Energy CenterSR OneThe Column GroupThird Rock VenturesVenrockVenrock Healthcare Capital Partners

Investors

Cormorant Asset ManagementFidelityHillhouse InvestmentSR OneVenrock